Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Assets Average (2018 - 2025)

Arcus Biosciences (RCUS) has 8 years of Assets Average data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Assets Average changed N/A year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, changed N/A, while the annual FY2023 figure was $1.2 billion, 17.19% down from the prior year.
  • Assets Average reached $1.1 billion in Q4 2025 per RCUS's latest filing, down from $1.2 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.6 billion in Q1 2022 and bottomed at $853.7 million in Q1 2021.
  • Average Assets Average over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2025.
  • Peak YoY movement for Assets Average: soared 350.2% in 2021, then fell 18.54% in 2023.
  • A 5-year view of Assets Average shows it stood at $1.2 billion in 2021, then rose by 10.8% to $1.3 billion in 2022, then dropped by 15.14% to $1.1 billion in 2023, then grew by 9.36% to $1.2 billion in 2024, then dropped by 15.48% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $1.1 billion in Q4 2025, $1.2 billion in Q1 2025, and $1.2 billion in Q3 2024.